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Abstract The influence of hepatitis B virus (HBV) and hep-
atitis C virus (HCV) coinfection on liver histology in children
remains unknown. We analyzed histopathological features in
70 treatment-naïve children: 10 with HBV/HCV coinfection
(case group A), 30 with HBV (control group B), and 30 with
HCV (control group C). Liver biopsies were scored for grad-
ing and staging according to Knodell’s modified system and
were tested for an association with demographic and labora-
tory data. The mean grade was higher in coinfected children
compared to control group C (6.2±3.0 vs. 4.2±2.5, p=0.04),
but not control group B (p=0.47). A higher proportion of
patients with moderate to severe necroinflammation were
observed in case group A compared to isolated HCV (p=
0.05). Mean staging did not differ between the case and
control groups. Multivariate analysis revealed that HBV/
HCV coinfection and aminotransferase activity were
independently associated with moderate to severe
necroinflammatory activity
Conclusion: HBV/HCV coinfection was associated with
moderate to severe necroinflammation irrespective of age at
biopsy or duration of infection and led to significantly higher
necroinflammatory activity than HCV monoinfection. HBV/
HCV coinfection did not enhance fibrosis. High aminotrans-
ferase levels were positively associated with moderate to
severe necroinflammation.
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Introduction
Hepatitis B virus (HBV) and hepatitis C virus (HCV) are the
most common causes of chronic liver disease, leading to
important global public health problems [28]. According to
the World Health Organization (WHO), 350 million people
worldwide are chronically infected with HBVand 170 million
with HCV [4, 28]. Because the two viruses share modes of
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transmission, HBV and HCV coinfection is rather common,
especially in endemic areas and among patients with a high
risk of parenteral infections [4, 17]. Approximately 2–10 % of
HCV-infected individuals are HBsAg-positive, whereas the
presence of anti-HCV is confirmed in 5–20 % of patients with
HBV infection [4, 17, 25]. However, the exact number of
patients with coinfection is unknown but is thought to be
higher [25]. The literature suggests that coinfection with
HBV and HCV may have considerable clinical relevance.
Dual infection is associated with more severe liver disease
and frequent progression to cirrhosis and hepatocellular can-
cer [9, 23, 24]. However, some evidence exists for reciprocal
replicative suppression between both viruses [2, 9]. Informa-
tion concerning many aspects of coinfection is currently in-
complete and controversial [23, 25]. Moreover, only sparse
and inconsistent data are available regarding chronic HBVand
HCV coinfection in the pediatric population [22, 26, 27].
Several studies have reported that children with chronic viral
hepatitis tend to have milder disease than adults [10, 11, 15].
However, the impact of dual infection acquired in early child-
hood remains unknown. Therefore, the aim of the present
study was to analyze the histopathological features in children
with HBV and HCV coinfection and to compare them to
patients with HBVor HCV monoinfection. The analysis also
included factors associated with necroinflammation and fibro-
sis in the liver.
Methods
Patients
Seventy-one consecutive pediatric patients with confirmed
chronic viral hepatitis undergoing liver biopsy in our depart-
ment between 2001 and 2012 were analyzed retrospectively.
Liver biopsy was performed as part of the qualification pro-
cedure for antiviral therapy. Patients were qualified for liver
biopsy (and treatment) on the basis of the current practical
guidelines of the European Association for the Study of the
Liver (EASL) and according to the national therapeutic pro-
grams. Briefly, we included children over 3 years of age with
the following additional criteria: (1) for HBV-infected pa-
tients, either persistently increased aminotransferase levels
and/or HBV DNA levels >2,000 IU/ml, and (2) for HCV-
infected children, detectable HCV RNA regardless of the
aminotransferase pattern [7, 8]. HIVor HDV-infected children
were not included. In addition, other well-established causes
of liver disease, such as autoimmune hepatitis, Wilson’s dis-
ease, alpha 1-antitrypsin deficiency, or nonalcoholic fatty liver
disease (NAFLD), were exclusion criteria for this study. Prob-
able modes and dates of transmission were determined based
on the available medical records. The age when the infection
was acquired and the duration of the disease were calculated
from the beginning of risk exposure. According to these data,
all children with HBV/HCV coinfection were infected simul-
taneously with both viruses. Chronic hepatitis was diagnosed
in children with >6-month history of viral hepatitis on the
basis of elevated alanine and aspartate aminotransferase (ALT
and AST, respectively) activities, serological testing, and
nucleic acid testing. ALT and AST serum levels were mea-
sured using commercially available laboratory tests (Vitros,
Ortho Clinical Diagnostics, Johnson & Johnson). For both
ALT and AST, 40 IU/l was considered the upper limit of
normal (ULN). Serum markers of HBV infection (HBsAg,
HBeAg, anti-HBeAg, anti-HBc, anti-HBs) were measured
with commercially available ELISA kits (Vitros ECi, Ortho
Clinical Diagnostics, Johnson & Johnson). Anti-HCV was
determined using a third-generation ELISA test (Ortho Vitros
ECi, Ortho Clinical Diagnostics, Johnson & Johnson). HBV
DNA and HCV RNAwere detected using real-time polymer-
ase chain reaction (RT-PCR) (Amplico, Roche, and Cobas
TaqMan, Roche). Chronic hepatitis B was diagnosed on the
basis of HBsAg positivity and was confirmed by PCR positive
for HBV DNA, whereas chronic hepatitis C was diagnosed in
anti-HCV-positive children and was confirmed by PCR pos-
itive for HCVRNA. HBV/HCV coinfection was diagnosed in
children positive for both HBsAg and anti-HCV and was
confirmed by the detection of HBV DNA and HCV RNA.
Body mass index (BMI) standard deviation (SD) scores (BMI
z-scores) were calculated according to the WHO Child
Growth Standards and Growth reference data using the
WHO anthropometric calculator AnthroPlus v.1.0.4. Obesity
was diagnosed when the BMI z-score was >2 SD.
Liver biopsy
Percutaneous liver biopsy was performed using the Menghini
needle (Hepafix kit 1.4 or 1.6 mm, Braun). All biopsy spec-
imens were fixed in 4 % buffered formalin and routinely
processed in paraffin. Serial 4-μm-thick slides were stained
with hematoxylin and eosin, impregnated with silver accord-
ing to the Gomori method for reticulin fibers, and stained with
Chromotrope 2R and aniline blue for collagen fibers. The
histological evaluation was performed by one pathologist
experienced in hepatopathology (BWZ) who was blinded to
the clinical data. The histology was assessed according to
Knodell’s numerical scoring system modified by international
experts [3, 5, 16]. Necroinflammatory activity was graded as
the final sum of points in three categories: periportal and
bridging necrosis, intralobular necrosis, and portal inflamma-
tion, which gave a histologic activity index (HAI) ranging
from 0 to 18 points. The necroinflammation grade was con-
sidered minimal when HAI was 0–3 points, mild if 4–8 points,
moderate if 9–12 points, and severe if 13–18 points. The
fibrosis stage was assessed using a five-point scale: 0, no
fibrosis; 1, portal fibrosis, fibrous portal expansion; 2,
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periportal fibrosis, periportal or scarce portal-portal septa; 3,
septal fibrosis, fibrous septa with architectural distortion; and
4, cirrhosis. In addition, we analyzed the presence of the
following abnormalities: portal lymphoid aggregates/follicles
(lymphadenoplasia) and steatosis.
Statistical analysis
Data were tested for normal distribution using the
Kolmogorov-Smirnov test. Continuous variables were pre-
sented as means±SDs or medians with interquartile ranges
(IQRs) and were compared using either Student’s t test or
Mann-Whitney test. Categorical variables were compared
using either the chi-square test or Fisher’s exact test, as ap-
propriate. Even though grading and staging are both categor-
ical variables, mean grading and staging scores were calculat-
ed as in other papers in order to make a comparison with the
results of the other authors possible [21, 24, 28].
The Kruskal-Wallis test or analysis of variance was used to
compare age at biopsy, age at infection acquisition, duration of
infection, and ALT and AST activity in patient subgroups
according to the grade and staging. Stepwise logistic regres-
sion with the accompanying C statistic was used to determine
factors associated with moderate to severe necroinflammation
(grade ≥9 points) or fibrosis (staging ≥3 points). The follow-
ing variables were entered into the model: HBV/HCV coin-
fection, HBVmonoinfection, HCVmonoinfection, sex, age at
liver biopsy, age at infection, duration of infection, ALT
activity, and AST activity. The Hosmer-Lemeshow
goodness-of-fit test was used to assess the model fit. Consid-
ering a strong correlation between ALTand AST, two separate
models were constructed to avoid multicollinearity: model 1
including ALT and model 2 including AST.
A two-sided p value of <0.05 was considered significant.
All statistical analyses were performed using MedCalc Statis-
tical Software ver. 12.1.4.0 (MedCalc, Mariakerke, Belgium).
Results
Baseline characteristics of the study population
A total of 77 liver biopsy specimens obtained from 71 con-
secutive children with chronic viral hepatitis were analyzed.
Five children underwent a repeat liver biopsy, including one
who had three biopsies. In these cases, only the initial biopsy
was analyzed. In one case, fragmentation of the tissue pre-
cluded a reliable assessment of the specimen (Fig. 1). The
final analysis comprised 70 treatment-naïve patients (48 boys
and 22 girls, aged 5–17 years, mean 12.2±3.1 years) divided
into three groups: 10 (14 % of the study group) with chronic
HBV/HCV coinfection, 30 (43 %) with chronic hepatitis B,
and 30 (43 %) with chronic hepatitis C. Children with HBV/
HCV coinfection (case group A) were compared to those with
HBV monoinfection (control group B) and HCV
monoinfection (control group C). The statistical analysis did
not reveal any significant differences between case group A
and the control groups with respect to the proportion of
male/female patients, age at liver biopsy, duration of infection,
age at infection, BMI, BMI z-score, HBVand HCV viral load,
or mode of transmission (Table 1). Most subjects acquired the
infection nosocomially. Ten percent of children in both control
groups were vertically infected, but no case of vertical trans-
mission was reported among patients with coinfection. The
distribution of genotypes in children with HBV infection was
as follows: A (50 %) and D (50 %). Genotype 1 (1a and 1b)
was detected in 86 % of all children with HCV infection,
genotype 3a in 9 %, and genotype 4 in 5 %.
Liver histopathology
Children with HBV/HCV coinfection most often presented
with mild to moderate necroinflammation and stage 2 fibrosis
(Table 2). The mean grade was significantly higher in case
group A compared to control group C (p=0.04), but no
difference was found with control group B (p=0.47, Table 2,
Fig. 2). In addition, a higher proportion of patients in case
group A had moderate to severe necroinflammation compared
to control group C (p=0.05, Table 2), but not when compared
to control group B (p=0.2, Table 2). The mean staging values
and proportions of patients with each staging score did not
differ between the studied groups. The presence of lymphoid
aggregates was confirmed in 25/70 (36 %) patients, and
steatosis was found in 11/70 (16 %) patients in the study
Fig. 1 Flowchart of patient selection
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group. No significant differences were found in the prevalence
of lymphadenoplasia and steatosis between case group A and
both controls.
In a univariate analysis, both ALT and AST activities were
associated with moderate to severe necroinflammation (grade
≥9 points, p=0.0042 and p=0.009, respectively, Table 3).
Multivariate analysis revealed that HBV/HCV coinfection
(p=0.03 and p=0.04 depending on model) and ALT (p=
0.003) and AST (p=0.007) activity were independently asso-
ciated with moderate to severe necroinflammatory activity
(grade ≥9 points, Table 3). None of the analyzed parameters
were predictors of severe fibrosis (staging ≥3 points).
We observed a trend toward more advanced fibrosis in
patients with older age at liver biopsy (p=0.06). However,
we observed no differences in the age at infection (p=0.43),
duration of infection (p=0.24), ALT activity (p=0.18), and
AST activity (p=0.27) in subgroups divided according to
fibrosis staging. On the other hand, ALT and AST activities
were significantly different between subgroups with consecu-
tive necroinflammation grades (Fig. 3). Age at liver biopsy,





















Mean±SD 5.0±2.9 6.2±3.0 5.4±3.4 4.2±2.5 0.47 0.04 0.12
Minimal (0–3) (%) 18 (26) 2 (20) 7 (24) 9 (30) 0.2 0.05 0.22
Mild (4–8) (%) 43 (61) 5 (50) 18 (60) 20 (67)
Moderate (9–12) (%) 8 (11) 3 (30) 4 (13) 1 (3)
Severe (13–18) (%) 1 (3) 0 1 (3) 0
Staging of fibrosis
Mean±SD 1.5±0.9 1.7±0.8 1.7±0.9 1.2±0.9 0.92 0.14 0.036
0 (%) 9 (13) 1 (10) 2 (7) 6 (20) 0.69 0.33 0.32
1 (%) 26 (37) 2 (20) 11 (36.5) 13 (43)
2 (%) 26 (37) 6 (60) 11 (36.5) 9 (30)
3 (%) 8 (11.5) 1 (10) 5 (17) 2 (7)
4 (cirrhosis) (%) 1 (1.5) 0 1 (3) 0
Grading (0–3)+staging (0) (%) 7 (10) 1 (10) 2 (7) 4 (13) 1.0 1.0 0.67
Grading (9–18)+staging (3–4) (%) 3 (4) 1 (10) 1 (3) 1 (3) 0.44 0.44 1.0
Fig. 2 Mean grading in case
group HBV/HCV compared to
monoinfection control groups.
Error bars indicate standard
deviations
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age at infection, and duration of infection did not differ be-
tween patients with different grades (p=0.53, p=0.83, and p=
0.35, respectively).
Histopathological evaluation did not reveal any significant
changes in one patient with coinfection, which was similar to
two children with HBV and four with HCV alone. In one
patient with coinfection (10 %), both necroinflammation and
fibrosis were advanced (grading 11, staging 3), compared to
one (3%) in control group B and one (3%) in control group C.
Cirrhosis was present in only one patient (a 14-year-old boy
infected nosocomially with HBV at the age of 3 years, with
ALT and AST serum levels between 1 and 1.5 ULN: ALT
54 IU/l and AST 44 IU/l).
Discussion
Chronic viral hepatitis in childhood is usually a benign disease
and does not lead to severe liver damage [10, 11]. However, in
this study, we demonstrated a wide spectrum of histopatho-
logical lesions in children with chronic viral hepatitis, includ-
ing mild to severe necroinflammation and fibrosis. Previous
studies have shown that HBV/HCV coinfection in adults is
associated with more severe liver disease than monoinfection
with either virus [9, 23, 24]. However, data in children with
coinfection are limited [22, 26, 27]. Morphological changes in
patients with HBV/HCV coinfection in our study comprised
lesions, which are common to the etiologies of both HBVand
HCV [12].
In the present study, multivariate analysis revealed that
HBV/HCV coinfection is an independent factor associated
with a higher risk of moderate to severe necroinflammatory
activity in children, which is a unique finding. No such cor-
relation was found for severe fibrosis. In addition, we showed
that necroinflammatory activity is more pronounced in chil-
dren with HBV/HCV coinfection than in children with HCV
monoinfection, but no difference was found when comparing
coinfection to patients infected with HBV only. HBV and
HCVare two different viruses that contain disparate genomes
and distinct replication mechanisms. However, several differ-
ent outcomes can occur when the liver is affected simulta-
neously by these two viruses, including synergistic damage
and inhibited replication of the other virus [13]. Sagnelli et al.
observed that HBV infection speeds up the progression of
hepatitis related to HCV, despite the reciprocal inhibition of
viral genomes [24]. However, a stimulating role of HCVin the
progression of chronic hepatitis B is also possible [13, 17, 24,
28]. Similarly, in patients with HBV/HCV coinfection, the
presence of HCVmay improve clinical outcomes compared to
the expected outcome of chronic hepatitis B alone [13].
The proportion of children in whom no significant mor-
phological changes were found in the liver was relatively low
(10 %) in the coinfection group and similar to the groups with
monoinfection (7 % in control group B and 13 % in control
group C). In contrast, Goodman et al. reported nearly normal
biopsies or only minimal inflammation in 52 (43 %) out of
110 studied liver biopsies in children with chronic hepatitis C
[10]. In our study, although the absolute percentages sug-
gested a higher proportion of children with both advanced
necroinflammation (grade ≥9 points) and fibrosis (staging ≥3
Table 3 Factors associated with moderate to severe necroinflammatory activity (grading ≥9)
Parameter Univariate analysis Multivariate analysis model 1 Multivariate analysis model 2
Odds ratio (95 % CI) Odds ratio (95 % CI) Odds ratio (95 % CI)
HBV monoinfection 7.0 (0.82–59.5), p=0.07 – –
HCV monoinfection 0.57 (0.14–2.3), p=0.43 – –
HBV/HCV coinfection 3.78 (0.77–18.6), p=0.10 8.4 (1.2–57.5), p=0.03 7.3 (1.09–48.6), p=0.04
Age at infection 0.77 (0.44–1.34), p=0.36 – –
Duration of infection 1.27 (0.98–1.64), p=0.07 – –
Age at liver biopsy 1.23 (0.93–1.62), p=0.14 – –
ALT 1.02 (1.005–1.03), p=0.0042 1.02 (1.007–1.03), p=0.003 –
AST 1.03 (1.007–1.05), p=0.009 – 1.03 (1.009–1.06), p=0.007
Sexa 0.86 (0.19–3.81), p=0.84 – –
Model performance
AUC 0.90 (0.80–0.96) 0.862 (0.758–0.933)
Hosmer-Lemeshow goodness-of-fit testb 10.7, 8, p=0.22 12.9, 7, p=0.07
Considering a strong correlation between ALT and AST, two separate models were constructed to avoid multicollinearity: model 1 including ALT and
model 2 including AST
a For male sex
bData are χ2 statistic, degrees of freedom, and p value; a high p value indicates a good fit of the data with the model
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points) among the coinfected patients (10 %) compared to
both control groups (3 % in both groups), the observed dif-
ference did not reach significance, probably due to the small
numbers of patients in each group.
The presence of cirrhosis in only one patient precluded any
reliable analysis concerning factors associated with cirrhosis
in pediatric patients with chronic viral hepatitis. Nevertheless,
the fact that we observed cirrhosis in a 14-year-old boy with
an 11-year history of HBV infection is particularly important.
Further studies are needed to assess the true incidence of
cirrhosis in children with chronic viral hepatitis.
The mean HAI in our pediatric cohort with HBV/HCV
coinfection was similar to that observed by Sagnelli et al. in
27 adult patients with coinfection (6.2±3.0 vs. 5.8±3.4 points,
p=0.75). The same was found for fibrosis (mean staging score
1.7±0.8 in our study vs. 2.1±1.2 in adults, p=0.25) or control
groups B and C [24]. These facts underscore that HBV/HCV
coinfection in children is as aggressive as in adults. However,
further prospective studies are needed to directly compare
histopathological changes in children and adults coinfected
with HBV/HCV.
Conflicting data exist on the influence of patient age or
duration of infection with both HBV and HCVon histopath-
ological lesions in the liver [1, 6, 10, 20, 21]. In the present
study, we found a trend toward higher staging in patients with
older age at liver biopsy (p=0.06). However, we did not
Fig. 3 Aminotransferase levels
based on necroinflammation
grades: 1 (minimal, 0–3 points), 2
(mild, 4–8), 3 (moderate, 9–12),
and 4 (severe, 13–18). a ALT
versus grading. Kruskal-Wallis
test p=0.0003. b AST versus
grading. Kruskal-Wallis test p=
0.005
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confirm the correlation between age at infection or duration of
infection and the severity of histopathological changes in the
liver. Thus, severe liver damage as a consequence of chronic
hepatitis is possible even in young children, irrespective of the
duration of infection or age at infection. These facts call into
question the benign nature of chronic hepatitis in children.
Data on the relationship between aminotransferase activity
and the severity of histopathological features in the liver are
also conflicting. According to Hudacko and Theise, serum
transaminase levels are increased in almost all patients with
chronic hepatitis, but the levels do not necessarily reflect the
severity of necroinflammatory activity [14]. Up to 30 % of
HBV-infected patients with persistently normal ALT levels are
estimated to have significant fibrosis, and 10 % may have
bridging fibrosis or cirrhosis, which indicates that normal ALT
does not exclude progressive liver disease [10, 18]. We dem-
onstrated that ALT and AST activities are independently as-
sociated with moderate to severe necroinflammation (grade
≥9 points), but not fibrosis. Similar observations have been
made by other authors in patients with chronic hepatitis C [1,
10, 19]. Interestingly, Badizadegan et al. showed a significant
correlation between ALT levels and HAI in children with
chronic hepatitis C, but the strength of the correlation
depended on the grading scheme used for histopathological
assessment [1].
Limitations
As a cross-sectional study, our study did not permit us to
distinguish between causes and effects. Thus, the causal rela-
tionship between variables demonstrating an association in
our study needs to be confirmed in prospective cohort studies.
In addition, the slides were read by one pathologist. Taking
into consideration an interobserver variation, an additional
pathologist could make the results more reliable. A limitation
of the study was a relatively small number of subjects in the
case group. In particular, the conclusion that HBV/HCV co-
infection was associated with higher necroinflammatory ac-
tivity when compared to HCV monoinfection, whereas no
difference existed with HBV monoinfection, may result from
the low number of children with coinfection taken into con-
sideration. However, papers on children are lacking in this
field, and the information regarding the results of liver biop-
sies in children with coinfection should be considered unique,
whereas comparisons between the case and control groups
may be undermined by the aforesaid limitations.
In conclusion, children with HBV/HCV coinfection pre-
sented with a wide range of histopathological features in the
liver, including severe necroinflammation and fibrosis, irre-
spective of age at liver biopsy, duration, and age at infection.
HBV/HCV coinfection was associated independently with
moderate to severe necroinflammation and led to significantly
higher necroinflammatory activity compared to HCV, but no
difference was found with HBV monoinfection. However,
HBV/HCV coinfection did not enhance fibrosis staging com-
pared to monoinfection. Moreover, high aminotransferase
l eve l s we re good pred i c to r s o f the deg ree o f
necroinflammation, but not fibrosis.
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